RJA
IRIX icon

Raymond James & Associates’s IRIDEX IRIX Stock Holding History

Raymond James & Associates’s Portfolio IRIX Stock Details IRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26,743
Closed -$189K – 4194
2021
Q2 		$189K Buy
+26,743
New +$203K ﹤0.01% 3697

Other funds holding IRIX

PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Raymond James & Associates's IRIX Position: Q3 2021 in Review

Raymond James & Associates sold out of IRIDEX (IRIX) in Q3 2021, closing a stake of 26,743 shares — an estimated $189K sold.

Raymond James & Associates first reported a position in IRIX in Q2 2021 and held it in 1 quarter. The position peaked at $189K in Q2 2021. 29 funds tracked by Wall St. Rank hold IRIX as of Q3 2021.

  • Raymond James & Associates reported no remaining IRIDEX position as of Q3 2021 after selling out during the quarter.
  • Raymond James & Associates sold 26,743 IRIDEX shares in Q3 2021, an estimated $189K.
  • Raymond James & Associates first reported a position in IRIDEX in Q2 2021 and held it in 1 quarter.
  • Raymond James & Associates's IRIDEX position peaked at $189K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held IRIDEX as of Q3 2021.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.